Increasing glutathione levels lowers Alzheimer’s pathology and improves cognitive decline

alzheimer
Credit: Unsplash/CC0 Public Domain

Australian researchers have shown that a dietary supplement that increases the levels of a powerful antioxidant in the brain may represent a novel strategy for the treatment and/or prevention of cognitive impairment and debilitating neurodegenerative diseases such as Alzheimer’s disease.

Findings of the study were recently published in Neurochemistry International.

A team of researchers from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA), and the School of Biotechnology and Biomolecular Sciences (BABS), has shown that dietary supplementation with glutathione precursor γ-glutamylcysteine (γ-GC), marketed as…

Read more…